Biopsy Techniques and Diagnoses & Treatment of Mucocutaneous Lesions

Dental Clinics of North America

Volumn 56, Issue 1, 2012, Pages 43-73

  Chan, Michael H ^a,b   Wolf, Joshua C ^b  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b BROOKLYN HOSPITAL CENTER   (United States)

Author keywords

Biopsy; Immune based lesions; Mucocutaneous; Treatment; Vesiculobullous

Indexed keywords

APHTHOUS STOMATITIS; BIOPSY; DRUG CONTRAINDICATION; ERYTHEMA MULTIFORME; GENERAL PRACTICE; HERPES LABIALIS; HERPETIC STOMATITIS; HUMAN; INSTRUMENTATION; LICHEN PLANUS; METHODOLOGY; MOUTH DISEASE; MUCOUS MEMBRANE PEMPHIGOID; PEMPHIGUS; REVIEW; SKIN LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS;

BIOPSY; ERYTHEMA MULTIFORME; GENERAL PRACTICE, DENTAL; HERPES LABIALIS; HUMANS; LICHEN PLANUS, ORAL; LUPUS ERYTHEMATOSUS, CUTANEOUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MOUTH DISEASES; PEMPHIGOID, BENIGN MUCOUS MEMBRANE; PEMPHIGUS; STOMATITIS, APHTHOUS; STOMATITIS, HERPETIC;

EID: 82155171468     PISSN: 00118532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cden.2011.09.004     Document Type: Review

References (55)

1. Shulman J., Beach M., Rivera-Hidalgo F. The prevalence of oral mucosal lesions in U.S. adults: data from the Third National Health and Nutrition Examination Survey, 1988-1994. J Am Dent Assoc 2004, 135:1279.
2. Shulman J., Beach M., Rivera-Hidalgo F. Prevalence of oral mucosal lesions in children and youths in the USA. Int J Paediatr Dent 2005, 15:89.
3. American Dental Association The 2005-06 Survey of Dental Services Rendered 2007, ADA.
4. Kerpel S, Freedman P, Reich R. A comprehensive review course in oral pathology [handout]. 2002.
5. Sapp J.P., Eversole L.R., Wysocki G.P. Contempoary oral & maxillofacial pathology 2004, Mosby, St. Louis (MO), p. 210-3. 2nd edition.
6. Scully C., Porter S. Oral mucosal disease: recurrent aphthous stomatitis. Br J Oral Maxillofac Surg 2008, 46:198-206.
7. Scully C., Porter S. Recurrent aphthous stomatitis: current concepts of etiology, pathogenesis and management. J Oral Pathol Med 1989, 18:21-27.
8. Thorn J.J., Holstrupp P., Rindum H., et al. Course of various clinical forms of oral lichen planus. A prospective follow-up study of all 611patients. J Oral Pathol Med 1988, 17:213-318.
9. Toscano N.J., Holtzclaw D.J., Shumaker N.D. Surgical considerations and management of patients with mucocutaneous disorders. Compend Contin Educ Dent 2010, 31:346.
10. Rogers R.S., Eisen D. Erosive OLP with genital lesions. The vulvovaginal-gingival syndrome and peno-gingival syndrome. Dermatol Clin 2003, 21(1):79-89.
11. Anderson J.O. OLP: a clinical evaluation of 115 cases. Oral Surg Med Oral Pathol 1968, 23(1):31-41.
12. Lourenco S.V., Boggio P., Agner Macado Martins L.E., et al. childhood oral mucous membrane pemphigoid presenting as desquamative gingivitis in a 4-year-old girl. Acta Derm Venereol 2006, 86(4):351-354.
13. Endo H., Rees T.D., Kuyama K., et al. Clinical and diagnostic features of mucous membrane pemphigoid. Compend Contin Educ Dent 2006, 27(9):512-518.
14. Suresh L., Kumar V. Significance of IgG4 in the diagnosis of mucous membrane pemphiogoid. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007, 104(3):359-362.
15. Scully C., Challacombe S.J. Pemphigus: update on etiopathogenesis, oral manifestations, and management. Crit Rev Oral Boil Med 2002, 13(5):397-408.
16. Zunt S. Transepithelial brush biopsy: an adjunctive diagnostic procedure. J Indiana Dent Assoc 2001, 80(2):6-8.
17. Sciubba J. Improving detection of precancerous and cancerous oral lesions. Computer-assisted analysis of the oral brush biopsy. U.S. Collaborative OralCDx Study Grooup. J Am Dent Assoc 1999, (30):1445-1457.
18. Hohlweg-Majert B., Deppe H., Metzger M.C. Sensitivity and specificity of oral brush biopsy. Cancer Invest 2009, 27:293-297.
19. Golden D., Hooley J. Oral mucosal biopsy procedures. Excisional and incisional. Dent Clin North Am 1994, 38(2):279-300.
20. Marx R.E., Stern D. Oral and maxillofacial pathology: a rationale for diagnosis and treatment 2003, Quintessence books, Carol Stream (IL), p. 1-15.
21. Lynch D., Morris L. The oral mucosal punch biopsy: indications and technique. J Am Dent Assoc 1990, 121:145-149.
22. White J., Chaudhry S. Nd:Yag and CO2 Laser Therapy of Oral mucosal Lesions. J Clin Laser Med Surg 1998, 16(6):299-304.
23. Oliver R., Sloan P. Oral Biopsies: methods and applications. Br Dent J 2004, 196(6):329-333.
24. Hull C., Brunton S. The role of topical 5% acyclovir and 1% hydrocortisone cream (xerses) in the treatment of recurrent herpes simplex labialis. Postgrad Med 2010, 122(5):1-6.
25. Kwandala A. 5% amlexanox oral paste, a new treatment for recurrent minor aphthous ulcers: I. Clinical demonstration of acceleration of healing and resolution of pain. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997, 83(2):222-230.
26. Greer R.O., Lindenmuth J.E. A double-blind study of topically applied 5% amlexanox in the treatment of aphthous ulcers. J Oral Maxillofac Surg 1993, 51(3):243-248. [discussion: 248-9].
27. Binnie W.H., Curro F.A. Amlexanox oral paste: a novel treatment that accelerates the healing of aphthous ulcers. Compend Contin Educ Dent 1997, 18(11):1116-1118. 1120-2, 1124 passim.
28. Murray B., McGuinness N., Biagioni P., et al. A comparative study of the efficacy of Aphtheal in the management of recurrent minor aphthous ulceration. J Oral Pathol Med 2005, 34(7):413-419.
29. Murray B., Biagioni P.A., Lamey P.J. The efficacy of amlexanox OraDisc on the prevention of recurrent minor aphthous ulceration. J Oral Pathol Med 2006, 35(2):117-122.
30. Khandwala A., Van Inwegen R.G., Charney M.R., et al. 5% amlexanox oral paste, a new treatment for recurrent minor aphthous ulcers: II. Pharmacokinetics and demonstration of clinical safety. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997, 83(2):231-238.
31. Addy M., Tapper-Jones L., Seal M. Trial of astringent and antibacterial mouthwashes in the management of recurrent aphthous ulceration. Br Dent J 1974, 136(11):452-455.
32. Addy M., Carpenter R., Roberts W.R. Management of recurrent aphthous ulceration. A trial of chlorhexidine gluconate gel. Br Dent J 1976, 141(4):118-120.
33. Addy M. Hibitane in the treatment of aphthous ulceration. J Clin Periodontol 1977, 4(5):108-116.
34. Hunter L., Addy M. Chlorhexidine gluconate mouthwash in the management of minor aphthous ulceration.A double-blind, placebo-controlled cross-over trial. Br Dent J 1987, 162(3):106-110.
35. Greenspan J.S., Gadol N., Olson J.A., et al. Antibody-dependent cellular cytotoxicity in recurrent aphthous ulceration. Clin Exp Immunol 1981, 44(3):603-610.
36. Guggenheimer J., Brightman V.J., Ship I.I. Effect of chlortetracycline mouthrinses on the healing of recurrent aphthous ulcers: a double-blind controlled trial. J Oral Ther Pharmacol 1968, 4(5):406-408.
37. Graykowski E.A., Kingman A. Double-blind trial of tetracycline in recurrent aphthous ulceration. J Oral Pathol 1978, 7(6):376-382.
38. Denman A.M., Schiff A.A. Recurrent oral ulceration treated with Mysteclin: a controlled study. Br Med J 1979, 1(6173):1248-1249.
39. Häyrinen-Immonen R., Sorsa T., Pettilä J., et al. Effect of tetracyclines on collagenase activity in patients with recurrent aphthous ulcers. J Oral Pathol Med 1994, 23(6):269-272.
40. Wu Y., Zhou G., Zeng H. A Randomized double-blind, positive-control trail of topical thalidomide in erosive oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010, 10:188-195.
41. Porter S.R., Jorge J. Thalidomide: a role in oral oncology?. Oral Oncol 2002, 38:527-531.
42. Handfield-Jones S., Allen B.R., Littlewood S.M. Dapsone use with oral-genital ulcers. Br J Dermatol 1985, 113:501.
43. Agha-Hosseini F., Borhan-Mojabi K., Monsef-Esfahani H.R. Efficacy of purslane in the treatment of oral lichen planus. Phytother Res 2010, 24:240-244.
44. Kromminga A., Sitaru C., Meyer J., et al. Cicatricial pemphigoid differs from bullous pemphigoid and pemphigoid gestationis regarding the fine specificity of autoantibodies to the BP180 NC16A domain. J Dermatol Sci 2002, 28(1):68-75.
45. Roh J.Y., Yee C., Lazarova Z., et al. The 120-kDa soluble ectodomain of type XVII collagen is recognized by autoantibodies in patients with pemphigoid and linear IgA dermatosis. Br J Dermatol 2000, 143(1):104-111.
46. Sakamoto K., Mori K., Hashimoto T., et al. Antiepiligrin cicatricial pemphigoid of the larynx successfully treated with a combination of tetracycline and niacinamide. Arch Otolaryngol Head Neck Surg 2002, 128(12):1420-1423.
47. Parisi E., Raghavendra S., Werth V.P., et al. Modification to the approach of the diagnosis of mucous membrane pemphigoid: A case report and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003, 95(2):182-186.
48. Ciarrocca K.N., Greenberg M.S. A retrospective study of the management of oral mucous membrane pemphigoid with dapsone. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999, 88(2):159-163.
49. Ahmed A.R., Colón J.E. Comparison between intravenous immunoglobulin and conventional immunosuppressive therapy regimens in patients with severe oral pemphigoid: effects on disease progression in patients nonresponsive to dapsone therapy. Arch Dermatol 2001, 137(9):1181-1189.
50. Kirtschig G., Murrell D., Wojnarowska F., et al. Interventions for mucous membrane pemphigoid/cicatricial pemphigoid and epidermolysis bullosa acquisita: a systematic literature review. Arch Dermatol 2002, 138(3):380-384.
51. Chainani-Wu N., Silverman S., Lozada-Nur F., et al. Oral lichen planus: patient profile, disease progression and treatment responses. J Am Dent Assoc 2001, 132(7):901-909.
52. Stanley J.R. Therapy of pemphigus vulgaris. Arch Dermatol 1999, 135(1):76-78.
53. Fine J.D. Management of acquired bullous skin diseases. N Engl J Med 1995, 333(22):1475-1484.
54. Darling M., Daley T. Blistering mucocutaneous disease of the oral mucosa-a review: part 1. Mucous membrane pemphigoid. J Can Dent Assoc 2005, 71:851-854.
55. Darling M.R., Daley T. Blistering mucocutaneous diseases of the oral mucosa-a review: part 2. Pemphigus vulgaris. J Can Dent Assoc 2006, 72(1):63-66.